Allergy & Asthma Network applauds the Biden Administration and FDA on their decision to propose new standards prohibiting the sale of menthol cigarettes.
The President has signed into law federal food allergy legislation that will require sesame to be included as a potential allergen on food label packages.
The U.S. Senate is considering legislation that would improve step therapy policies and ensure patients are able to access their prescribed treatments.
Allergy & Asthma Network joins national health organizations in urging Congress to support a transition to zero-emission vehicles.
The president has signed into law HR 2468, the school based allergies and asthma management program act (SAMPRO) to help schoolchildren with asthma.
U.S. Department of Transportation (DOT) issued new rules no longer recognizing emotional support animals as service animals.
Elijah passed away after he had an anaphylactic reaction to a grilled cheese at his daycare. Elijah’s family now advocates for better training in daycares
Allergy & Asthma Network is pleased to see the Trump Administration take action to reduce drug prices, including prices for allergy and asthma medications.
Learn about our efforts that bring an end to racial disparities affecting people with asthma, allergies and related conditions.
Read a summary of the 2020 virtual AADCH event and learn about priority legislative & regulatory issues for patients living with asthma & allergies.
The Network celebrates its 35th anniversary with a virtual Capitol Hill day, launch of new programs, more.
The Network advocates against step therapy which limits patient treatment options, and can be dangerous and time-consuming. Learn what you can do about it.
Allergy & Asthma Network works to help Americans with asthma, allergies and related conditions at the federal, state and local level. Making sure the patient’s voice is heard in legislation and policy issues is an important part of the Network’s advocacy work. Advocates play a crucial role in raising awareness, educating policymakers and the general public, removing barriers to care and making issues widely known to make medical care and treatment more accessible and effective. One key advocacy initiative is to ensure people living with asthma disparities have equal access to high-quality and affordable care.
The COVID-19 pandemic has brought new healthcare issues to the forefront, such as H.R. 7647, the “Preserving Patient Savings on Drug Costs Act.” This legislation delays increasing medication costs for a year after the pandemic ends, putting a cap on out-of-pocket costs, and allow drug-sharing coupons to count towards deductibles. It highlights the importance of all patients to get the medicine they need during the COVID-19 health crisis.